Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Pain 6Neoplasms 6Cancer Pain 6Pain, Intractable 2Multiple Myeloma 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Leukemia 2Waldenstrom Macroglobulinemia 1Vesico-Ureteral Reflux 1Ureteral Neoplasms 1Thrombocythemia, Essential 1Sigmoidal Tumour 1Sezary Syndrome 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pain, Postoperative 1Nephrolithiasis 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Mucositis 1Monoclonal Gammopathy of Undetermined Significance 1

Interventions

Ketamine 3Morphine 2Methadone 2resiniferatoxin 1Standard of Care 1Sodium Chloride 1Passive Cutaneous Anaphylaxis 1Hydromorphone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Pain, Intractable × Morphine × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT02687347 2016-09-20

UDOME

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 3 Unknown
204 enrolled

Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡